Trends Affecting Biopharmaceutical Manufacturing: Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.

Bibliographic Details
Published in:Pharmaceutical Technology Europe Vol. 33; no. 10; pp. 42 - 45
Main Author: Lin, David
Format: Journal Article
Published: MJH Life Sciences Oct2021
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=153212380&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 153212380
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17537967
        5NG
      jtl: Pharmaceutical Technology Europe
      issn: 17537967
      maglogo: N
    pubinfo:
      dt: Oct2021
      vid: 33
      iid: 10
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        153212380
        153212380
      ppf: 42
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Trends Affecting Biopharmaceutical Manufacturing: Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.
      aug:
        au: Lin, David
        affil: Senior director, Technical Research, BioPlan Associates
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N